Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Apr8g1541 | ATGCAAACCCACCTTCTGCTCTTCTATTGTTACGTTGGCCTCTCTCTTGTTTTTGCTGCAGATGATGAATTGTCAACTCTTCTCTCAATCAAATCCAATCTCATTGATCCAATGAACTATCTGAAGGACTGGCAACTACCAAGCAATGTGACACAGCAAGGTTCATACCATTGTAACTGGACTGGAGTTGGTTGCGACTCTAAAGGTTTGGTGGAAAGTCTTGACCTCTCGAACATGAACCTTAGTGGTCGTGTTTGGGACCATATTCAATTCCTTTCAAGCCTATCTTCTTTCAACATAAGCTGTAACAACTTTGCTTCATCACTGCCCAAATCACTGTCCAACCTCACCTCTCTGAAGAGCTTTGATGTGAGCCAGAACTACTTCACTGGCAGCTTTCCCACTGGTCTTGGAAGAGCTGCAGGACTGATATCAATTAACGCATCAAGCAATGATTTTTCGGGCTTTCTTCCTGAAGATATTGGAAATGCAACATTGCTTGAGAGTCTTGATTTTCGAGGGGGCTATTTTATAAGTTCAATCCCCAGGAGTTTTAAGAATTTGCAGAAACTCAAATTTCTAGGCCTTTCAGGCAATAACTTCACAGGGAGGATTCCAGGATATTTAGGGGAACTTACTTCTCTGGAGACATTGATTATGGGATACAATGAGTTTGAAGGTGAGATCCCTTCAGAGTTTGGCAACTTGACCAGTCTTCAATACCTTGACTTGGCTGTAGGCGGTCTCAGTGGAAAAATTCCACCTGAATTGGGTAAGGTGAAAAAACTCACCGTAATTTACTTGTATCATAACAAATTCGCAGGAAAAATACCACCTCAATTTGGCAACATTACTTCACTGGTATATTTGGACCTCTCTGACAATCAGATCTCAGGAGAGATTCCGCAAGAATTTACTAAATTGGAAAATCTTCAGCTCTTAAATTTGATGAGCAACAAACTAACTGGTCCTGTACCAGAGAAGCTTGGAGAATTGAAAAATTTACAGGTGCTTGAGTTATGGAAAAATTCTTTACAAGGTCCTTTGCCACTAAACCTTGGACAGAACTCTCCTTTGCAGTGGTTGGATGTGTCCTCTAACTCTTTATCAGGGGAGATCCCTCCAGGTTTGTGCACAAAAGGCAATCTCACTAAACTAATCCTCTTCAACAATTCCTTCACTGGTTCCATTCCAAGTGGACTTGCAAACTGTTCGTCTCTGGTGCGTGCTCGGATTCAGAACAATCTTATTTCTGGAACTATTCCAGTTGGATTTGGAAACCTCCTGGGCCTTCAACGGCTGGAGTTGGCAAAGAACAACTTCACTGGGCAAATTCCTACAGATATTACCTCATCCACATCACTGTCTTTCATTGATGTATCTTGGAACCACCTTGAGTCATCTCTACCGTCAGATATTCTTTCTATTCCAACCCTTCAAACCTTCATTGCCTCTCACAACAATTTTGGAGGAAACATCCCTGACGAGTTCCAGAATTGTCCATCTCTCTCAGTGCTGGATCTTTCAAACACCCATATATCTGGCACAATTCCAGAAAGTATTGCTTCTTGTCAAAAATTAGTGAACCTTAACCTTCGAAACAACGAATTGACGGGTGGAATCCCCAAATCAATCACAAACATGCCCACCTTATCTGTTCTTGATCTGTCCAACAATTCACTGACTGGCAGGATACCTGAAAACCTTGGCAGCTCCCCAGCTCTAGAAATGCTGAACCTGTCTTATAACAAACTTGAAGGCCCTGTACCCTCAAATGGGATGTTGGTGACCATAAATCCTAATGATCTTATTGGAAATGCAGGCCTTTGTGGAGGCATTCTCCCTCCATGTTCTGCCAGTTTGGCTGTGACACGCCAGCGAAGGAGCTCACATATCAGACACATCATCATTGGTTTTTTGACAGGCATTTCAGTGATTTTCTCTCTTGGTGCTGTATATTTTGGTGGTAGATGGGTATACAAGAGATGGTACTTGTATAATAATTTTATCCATGATTGGTTCAAACAAAGCAATGAAGATTGGCCCTGGAGGTTAGTAGCATTCCAGAGGATCAGTTTCACTAGTAGTGACATCCTAACTTGCATAAAGGAATCAAATGTCATAGGCATGGGGGGCACAGGTATTGTGTACAAAGCTGAAATACATAGACCTCACATAACCGTAGCCGTGAAGAAACTATGGAGGTCAAGGACAGACATAGAAAATGGCAATGATGTATTAAGAGAAGTGGAACTTCTGGGGAGACTTAGGCATAGGAATATTGTAAGACTGTTGGGGTATGTACACAATGAAAGGGATGTGATGATGGTTTACGAGTACATGCCTAACGGGAATCTTGGAACAGCCCTGCATGGAGAACAATCAGCAAGGTTGCTTGTTGACTGGGTCTCAAGGTACAATATAGCTCTTGGAGTTGCACAAGGCCTCAACTACCTCCACCATGATTGTCACCCACCAGTTATTCACAGGGATATCAAGTCTAACAACATACTCCTTGACGCAAATTTGGAGCCAAGAGTAGCAGATTTCGGGTTGGCAAGGATGATGATCCAAAAGAATGAGACTGTTTCAATGGTTGCTGGGTCATATGGATATATCGCACCAGAATATGGATACACTCTCAAGGTTGACGAAAAGATTGACATATATAGTTACGGAGTGGTACTTTTGGAGCTCGTAACTGGTAAAATGCCTTTAGATCCTGCATTTGAAGAATCTATCGACATTGTCGAATGGATAAGGAAGAAGAAAAACAACAAAGCTTTGTTAGAAGCACTGGATCCTACTATAGCTACTCAGTGCAAACATGTCCAAGAAGAAATGCTTCTTGTACTTCGTATTGCACTTCTATGTACCACAAAGCTTCCCAAGGAAAGACCATCCATGAGGGACATCATCACAATGCTTGGAGAGGCAAAACCAAGACGGAAAAGTGTTTGCCATAATGGGGAACAAGACAGTAGTAGCATGGAAAAGCCAACGATCTTTACCTCTTCCCCAGTAGTGAGTCTTCTGTAG | 3039 | 0.4222 | MQTHLLLFYCYVGLSLVFAADDELSTLLSIKSNLIDPMNYLKDWQLPSNVTQQGSYHCNWTGVGCDSKGLVESLDLSNMNLSGRVWDHIQFLSSLSSFNISCNNFASSLPKSLSNLTSLKSFDVSQNYFTGSFPTGLGRAAGLISINASSNDFSGFLPEDIGNATLLESLDFRGGYFISSIPRSFKNLQKLKFLGLSGNNFTGRIPGYLGELTSLETLIMGYNEFEGEIPSEFGNLTSLQYLDLAVGGLSGKIPPELGKVKKLTVIYLYHNKFAGKIPPQFGNITSLVYLDLSDNQISGEIPQEFTKLENLQLLNLMSNKLTGPVPEKLGELKNLQVLELWKNSLQGPLPLNLGQNSPLQWLDVSSNSLSGEIPPGLCTKGNLTKLILFNNSFTGSIPSGLANCSSLVRARIQNNLISGTIPVGFGNLLGLQRLELAKNNFTGQIPTDITSSTSLSFIDVSWNHLESSLPSDILSIPTLQTFIASHNNFGGNIPDEFQNCPSLSVLDLSNTHISGTIPESIASCQKLVNLNLRNNELTGGIPKSITNMPTLSVLDLSNNSLTGRIPENLGSSPALEMLNLSYNKLEGPVPSNGMLVTINPNDLIGNAGLCGGILPPCSASLAVTRQRRSSHIRHIIIGFLTGISVIFSLGAVYFGGRWVYKRWYLYNNFIHDWFKQSNEDWPWRLVAFQRISFTSSDILTCIKESNVIGMGGTGIVYKAEIHRPHITVAVKKLWRSRTDIENGNDVLREVELLGRLRHRNIVRLLGYVHNERDVMMVYEYMPNGNLGTALHGEQSARLLVDWVSRYNIALGVAQGLNYLHHDCHPPVIHRDIKSNNILLDANLEPRVADFGLARMMIQKNETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELVTGKMPLDPAFEESIDIVEWIRKKKNNKALLEALDPTIATQCKHVQEEMLLVLRIALLCTTKLPKERPSMRDIITMLGEAKPRRKSVCHNGEQDSSSMEKPTIFTSSPVVSLL* | 1013 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Apr8g1541 | 1012 | Gene3D | Phosphorylase Kinase; domain 1 | 701 | 784 | - | - | |
Apr8g1541 | 1012 | SUPERFAMILY | Protein kinase-like (PK-like) | 703 | 975 | IPR011009 | - | |
Apr8g1541 | 1012 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 827 | 839 | IPR008271 | GO:0004672|GO:0006468 | |
Apr8g1541 | 1012 | PANTHER | UNNAMED PRODUCT | 7 | 993 | - | - | |
Apr8g1541 | 1012 | PRINTS | Leucine-rich repeat signature | 287 | 300 | - | - | |
Apr8g1541 | 1012 | PRINTS | Leucine-rich repeat signature | 548 | 561 | - | - | |
Apr8g1541 | 1012 | SMART | LRR_typ_2 | 212 | 235 | IPR003591 | - | |
Apr8g1541 | 1012 | SMART | LRR_typ_2 | 428 | 452 | IPR003591 | - | |
Apr8g1541 | 1012 | SMART | LRR_typ_2 | 92 | 116 | IPR003591 | - | |
Apr8g1541 | 1012 | SMART | LRR_typ_2 | 548 | 572 | IPR003591 | - | |
Apr8g1541 | 1012 | SMART | LRR_typ_2 | 284 | 307 | IPR003591 | - | |
Apr8g1541 | 1012 | SMART | LRR_typ_2 | 332 | 356 | IPR003591 | - | |
Apr8g1541 | 1012 | Pfam | Leucine rich repeat N-terminal domain | 20 | 66 | IPR013210 | - | |
Apr8g1541 | 1012 | Gene3D | Ribonuclease Inhibitor | 143 | 250 | IPR032675 | - | |
Apr8g1541 | 1012 | Pfam | Leucine rich repeat | 262 | 321 | IPR001611 | GO:0005515 | |
Apr8g1541 | 1012 | Pfam | Leucine rich repeat | 526 | 585 | IPR001611 | GO:0005515 | |
Apr8g1541 | 1012 | MobiDBLite | consensus disorder prediction | 984 | 1012 | - | - | |
Apr8g1541 | 1012 | ProSiteProfiles | Protein kinase domain profile. | 702 | 983 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Apr8g1541 | 1012 | Gene3D | Ribonuclease Inhibitor | 22 | 141 | IPR032675 | - | |
Apr8g1541 | 1012 | Pfam | Protein kinase domain | 704 | 973 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Apr8g1541 | 1012 | Gene3D | Transferase(Phosphotransferase) domain 1 | 785 | 1001 | - | - | |
Apr8g1541 | 1012 | ProSitePatterns | Protein kinases ATP-binding region signature. | 708 | 732 | IPR017441 | GO:0005524 | |
Apr8g1541 | 1012 | SUPERFAMILY | L domain-like | 56 | 303 | - | - | |
Apr8g1541 | 1012 | Gene3D | Ribonuclease Inhibitor | 355 | 621 | IPR032675 | - | |
Apr8g1541 | 1012 | SUPERFAMILY | RNI-like | 229 | 582 | - | - | |
Apr8g1541 | 1012 | SMART | serkin_6 | 702 | 976 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Apr8g1541 | 1012 | PANTHER | LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE PXL1 | 7 | 993 | - | - | |
Apr8g1541 | 1012 | Gene3D | Ribonuclease Inhibitor | 251 | 354 | IPR032675 | - | |
Apr8g1541 | 1012 | MobiDBLite | consensus disorder prediction | 990 | 1012 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Apr8g1541 | Apr-Chr8 | 24950607 | 24954196 | Wgd |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Apr8g1541 | 4 | 1012 | Receptor kinase-like Gene Family | AT1G08590 | 64.279 | 0.0 | 1303 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_LRR-XI-1 | Apr8g1541 | Pkinase | 3.9e-49 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Apr8g1541 | - | - | gmx:100793873 | 1802.33 |